Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng-Chan Lin

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
IEEE Journal of Biomedical and Health Informatics|June 29, 2021
WinBinVec: Cancer-Associated Protein-Protein Interaction Extraction and Identification of 20 Various Cancer Types and Metastasis Using Different Deep Learning ModelsSina Abdollahi, Peng-Chan Lin, Jung-Hsien Chiang
IEEE/ACM Transactions on Computational Biology and Bioinformatics|September 27, 2021
DiaDeL: An Accurate Deep Learning-Based Model With Mutational Signatures for Predicting Metastasis Stage and Cancer TypesSina Abdollahi, Peng-Chan Lin, Jung-Hsien Chiang
European Journal of Haematology|January 19, 2005
Acute polymyositis after donor lymphocyte infusionPeng-Chan Lin, Liang-Tsai Hsiao, Po-Min Chen
Briefings in Bioinformatics|November 15, 2020
Precise uncertain significance prediction using latent space matrix factorization models: genomics variant and heterogeneous clinical data-driven approachesSina Abdollahi, Peng-Chan Lin, Meng-Ru Shen, et al.
International Journal of Molecular Sciences|July 14, 2018
Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem CellsPeng-Chan Lin, Hao-Yu Hsieh, Po-Chen Chu, et al.
Computational and Structural Biotechnology Journal|October 10, 2022
Literature-based translation from synthetic lethality screening into therapeutics targets: CD82 is a novel target for <i>KRAS</i> mutation in colon cancerHsih-Te Yang, Ming-Yu Chien, Jung-Hsien Chiang, et al.
Biomolecules|August 26, 2022
Cutting-Edge AI Technologies Meet Precision Medicine to Improve Cancer CarePeng-Chan Lin, Yi-Shan Tsai, Yu-Min Yeh, et al.
Plos One|August 25, 2018
Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in TaiwanJason C Hsu, Jia-Yu Lin, May-Ying Hsu, et al.
Plos One|December 13, 2019
Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatmentJason C Hsu, Jia-Yu Lin, Peng-Chan Lin, et al.
International Journal of Molecular Sciences|November 27, 2021
CD40 Pathway and IL-2 Expression Mediate the Differential Outcome of Colorectal Cancer Patients with Different <i>CSF1R</i> c.1085 GenotypesYu-Min Yeh, Peng-Chan Lin, Wu-Chou Su, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
IEEE Journal of Biomedical and Health Informatics|June 29, 2021
WinBinVec: Cancer-Associated Protein-Protein Interaction Extraction and Identification of 20 Various Cancer Types and Metastasis Using Different Deep Learning ModelsSina Abdollahi, Peng-Chan Lin, Jung-Hsien Chiang
IEEE/ACM Transactions on Computational Biology and Bioinformatics|September 27, 2021
DiaDeL: An Accurate Deep Learning-Based Model With Mutational Signatures for Predicting Metastasis Stage and Cancer TypesSina Abdollahi, Peng-Chan Lin, Jung-Hsien Chiang
European Journal of Haematology|January 19, 2005
Acute polymyositis after donor lymphocyte infusionPeng-Chan Lin, Liang-Tsai Hsiao, Po-Min Chen
Briefings in Bioinformatics|November 15, 2020
Precise uncertain significance prediction using latent space matrix factorization models: genomics variant and heterogeneous clinical data-driven approachesSina Abdollahi, Peng-Chan Lin, Meng-Ru Shen, et al.
International Journal of Molecular Sciences|July 14, 2018
Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem CellsPeng-Chan Lin, Hao-Yu Hsieh, Po-Chen Chu, et al.
Computational and Structural Biotechnology Journal|October 10, 2022
Literature-based translation from synthetic lethality screening into therapeutics targets: CD82 is a novel target for <i>KRAS</i> mutation in colon cancerHsih-Te Yang, Ming-Yu Chien, Jung-Hsien Chiang, et al.
Biomolecules|August 26, 2022
Cutting-Edge AI Technologies Meet Precision Medicine to Improve Cancer CarePeng-Chan Lin, Yi-Shan Tsai, Yu-Min Yeh, et al.
Plos One|August 25, 2018
Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in TaiwanJason C Hsu, Jia-Yu Lin, May-Ying Hsu, et al.
Plos One|December 13, 2019
Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatmentJason C Hsu, Jia-Yu Lin, Peng-Chan Lin, et al.
International Journal of Molecular Sciences|November 27, 2021
CD40 Pathway and IL-2 Expression Mediate the Differential Outcome of Colorectal Cancer Patients with Different <i>CSF1R</i> c.1085 GenotypesYu-Min Yeh, Peng-Chan Lin, Wu-Chou Su, et al.
Pageof 9